Search research articles
Contact Us
Filters
Showing results (31-40 of 66) with videos related to
Page
of 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2008
PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis
Grant D Barish, Annette R Atkins, Michael Downes, et al.
ESC Heart Failure
|
October 7, 2016
Mid wall fibrosis on CMR with late gadolinium enhancement may predict prognosis for LVAD and transplantation risk in patients with newly diagnosed dilated cardiomyopathy-preliminary observations from a high-volume transplant centre
Jose V Venero, Mark Doyle, Moneal Shah, et al.
Molecular Cancer Therapeutics
|
March 16, 2021
The KRAS<sup>G12C</sup> Inhibitor MRTX849 Reconditions the Tumor Immune Microenvironment and Sensitizes Tumors to Checkpoint Inhibitor Therapy
David M Briere, Shuai Li, Andrew Calinisan, et al.
Bioorganic & Medicinal Chemistry
|
August 4, 2022
Design and evaluation of achiral, non-atropisomeric 4-(aminomethyl)phthalazin-1(2H)-one derivatives as novel PRMT5/MTA inhibitors
Christopher R Smith, Ruth Aranda, James G Christensen, et al.
Cancer Research
|
November 7, 2023
TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors
A Cole Edwards, Clint A Stalnecker, Alexis Jean Morales, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2009
PPARgamma activation in adipocytes is sufficient for systemic insulin sensitization
Shigeki Sugii, Peter Olson, Dorothy D Sears, et al.
Cancer Discovery
|
August 6, 2021
Combined Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in NSCLC
Kwan Ho Tang, Shuai Li, Alireza Khodadadi-Jamayran, et al.
Neuro-Oncology Advances
|
June 8, 2026
Combining the KRAS<sup>G12C</sup> inhibitor adagrasib with anti-PD-1 immunotherapy improves overall survival and prevents recurrence in preclinical models of brain metastasis
Consuelo Torrini, Naema Nayyar, Gregory R Wojtkiewicz, et al.
Cancer Discovery
|
December 31, 2015
Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer
Andrew J Gunderson, Megan M Kaneda, Takahiro Tsujikawa, et al.
Nature Medicine
|
April 5, 2011
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A Collisson, Anguraj Sadanandam, Peter Olson, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 66) with videos related to
Sort By:
Page
of 7
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2008
PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis
Grant D Barish, Annette R Atkins, Michael Downes, et al.
ESC Heart Failure
|
October 7, 2016
Mid wall fibrosis on CMR with late gadolinium enhancement may predict prognosis for LVAD and transplantation risk in patients with newly diagnosed dilated cardiomyopathy-preliminary observations from a high-volume transplant centre
Jose V Venero, Mark Doyle, Moneal Shah, et al.
Molecular Cancer Therapeutics
|
March 16, 2021
The KRAS<sup>G12C</sup> Inhibitor MRTX849 Reconditions the Tumor Immune Microenvironment and Sensitizes Tumors to Checkpoint Inhibitor Therapy
David M Briere, Shuai Li, Andrew Calinisan, et al.
Bioorganic & Medicinal Chemistry
|
August 4, 2022
Design and evaluation of achiral, non-atropisomeric 4-(aminomethyl)phthalazin-1(2H)-one derivatives as novel PRMT5/MTA inhibitors
Christopher R Smith, Ruth Aranda, James G Christensen, et al.
Cancer Research
|
November 7, 2023
TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors
A Cole Edwards, Clint A Stalnecker, Alexis Jean Morales, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2009
PPARgamma activation in adipocytes is sufficient for systemic insulin sensitization
Shigeki Sugii, Peter Olson, Dorothy D Sears, et al.
Cancer Discovery
|
August 6, 2021
Combined Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in NSCLC
Kwan Ho Tang, Shuai Li, Alireza Khodadadi-Jamayran, et al.
Neuro-Oncology Advances
|
June 8, 2026
Combining the KRAS<sup>G12C</sup> inhibitor adagrasib with anti-PD-1 immunotherapy improves overall survival and prevents recurrence in preclinical models of brain metastasis
Consuelo Torrini, Naema Nayyar, Gregory R Wojtkiewicz, et al.
Cancer Discovery
|
December 31, 2015
Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer
Andrew J Gunderson, Megan M Kaneda, Takahiro Tsujikawa, et al.
Nature Medicine
|
April 5, 2011
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A Collisson, Anguraj Sadanandam, Peter Olson, et al.
Page
of 7